Yes but i should have stayed on it. The cancer is back they say
Member has chosen to not make this information public.
Member not yet following any Groups.
Member not yet following any Pages.
Leroy – I have been trying to find additional evidence that AO harmed civilians on Guam but not having any success so far. I believe this is because, in contrast to AF personnel, very few civilians were directly exposed to AO. The only exception I am aware of is the civilian heavy equipment company that was contracted for a time to haul the AO barrels from Naval Station to Andersen. Of the three men involved with this task, one died of non-Hodgkin lymphoma, one died of liver cancer, and the third is still alive but had testicular cancer (I tried to locate a copy of the contract but was unsuccessful).
God bless you and Ralph in your efforts to let the truth be known.
Robert L. Haddock, DVM, MPH
Guam Department of Public Health and Social Services
I handled, mixed by hand and power sprayed AGENT ORANGE HERBICIDES which included agent purple, agent white, agent orange and silvex which is the most deadly of all the herbicides because of its concentration of tcdd dioxin 7 times the amount in AGENT ORANGE. DR ROBERT HADDOCK CHIEF EPIDEMIOLOGIST FOR THE GUAM DEPARTMENT OF HEALTH AND HUMAN SERVICES COULD USE ALL OF THE MAYO CLINICS HELP WITH THE HEALTH EPIDEMICS CAUSED BY AGENT ORANGE HERBICIDES ON GUAM. HE IS FIGHTING A LOOSING BATTLE WITH THE US GOVERNMENT IGNORING THE HOLOCAUST I CAUSED.
@DeptVetAffairs i am very ill with AGENTORANGE HERBICIDES related diseases which are all autoimmune classified diseases which Admiral ZUMWALT warned our leaders about in 1991 but the VA, DOD, CONGRESS AND THE WHITEHOUSE CLASSIFIED HIS REPORT AND TESTIMONY SO THEY WOULDNT BE HELD ACCOUNTABLE OR RESPONSIBLE. I am fighting severe Parkinson’s like symptoms and severe cancers. I am sure i will be dead soon. Our medical community failed US. THEY FAILED TO LISTEN TO US. THEY FAILED TO STAND UP FOR DYING VETERANS AND THEIR GENETICALLY AFFECTED CHILDREN AND GRAND CHILDREN. I AM SO SAD AND SO HEART BROKEN AS I MURDERED 1000000S OF UNBORN BABIES AND COUNTLESS THOUSANDS OF VETERANS DIRECTLY EXPOSED TO AGENT ORANGE HERBICIDES ON GUAM WHERE I PERSONALLY HANDLED IT FOR 10 YEARS. I AM VERY VERY VERY SAD MAYO CLINIC HAS NOT STOOD UP FOR US TO DEMAND ANSWER’S. GOD FORGIVE ME AS I CONTEMPLATE MY LOT IN LIFE AND MY CHOICES TO END THE RELENTLESS PAIN.
VA and Stanford to Pursue the Nation’s First Hadron Center
Goal for the center will be to treat Veteran and non-Veteran patients using Hadron therapy
The U.S. Department of Veterans Affairs (VA) and Stanford Medicine announced today that they are collaborating to establish the nation’s first Hadron Center in Palo Alto, CA, for the benefit of Veteran and non-Veteran cancer patients who could benefit from Hadron therapy.
VA maintains a strong academic and research affiliation with Stanford Medicine. This long-standing partnership has enabled the VA Palo Alto Health Care System (VAPAHCS) to offer an exceptional breadth of medical services to Veterans. Now, VA and Stanford University are looking to expand and enhance this affiliation through new collaborative efforts around the Hadron Center and particle beam therapy for Veteran and non-Veteran patients with cancer.
During his 2016 State of the Union Address, President Obama called on Vice President Biden to lead a new, national Cancer Moonshot, focused on making a decade’s worth of progress in preventing, diagnosing, and treating cancer in five years – ultimately striving to end cancer as we know it. After meeting with experts across the country and the world, Vice President Biden identified areas of focus for the Cancer Moonshot – based on barriers to progress and opportunities for improving patient outcomes – and announced a first wave of accomplishments at the Cancer Moonshot Summit on June 29, 2016 at Howard University in Washington, DC.
Today, Vice President Biden is releasing the final report of the Cancer Moonshot Task Force, along with his own Executive Findings, after traveling to many of the major nerve centers in the cancer community. He will also unveil a new set of Federal actions, private sector actions, and collaborative partnerships to further advance the goals of the Cancer Moonshot Task Force, including the Hadron Center.
“We are excited to further expand our current partnership with Stanford Medicine, and explore ways to continue leading Veterans health care into the 21st century. The state-of-the-art Hadron Center would not only improve the lives of those affected by cancer, but further demonstrate VA’s ability to partner toward pioneering innovation and exceptional health care,” said VA Secretary Robert A. McDonald.
In addition to the Hadron Center, other efforts are underway to support the Cancer Moonshot Task Force: the Prostate Cancer Foundation (PCF) made a contribution of $50 million dollars to VA for precision oncology research over the next 5 years; the IBM Watson Million Veteran Initiative will provide 10,000 diagnostic and cancer treatment analyses over the next 2 years; and VA and PCF will host a national oncology summit, “Launch Pad: Pathways to InnoVAtion,” on November 29.
“These efforts underscore VA’s dedication and ability to work with private sector leaders and innovative academic institutions, like Stanford University, toward improving Veteran access to leading edge technology,” said VA Senior Advisor to the Secretary for Strategic Partnerships, Matthew S. Collier.
The Hadron Center is anticipated to be a clinical facility, designed to deliver particle radiation beam therapy for the treatment of cancer patients. Presently, the most common radiation beams used for cancer treatment are photons and electrons, which are easy to target to a tumor but can result in damage to normal tissue. Particle beam radiotherapy, on the other hand, uses beams of charged particles such as proton, helium, carbon or other ions to allow more precise targeting anywhere inside the patient’s body, resulting in less damage to normal tissue. Particle beam therapy can be more effective at killing radiation-resistant tumors that are difficult to treat using conventional radiation therapy. Judicious and innovative application of particle therapy can result in improved cure rates for cancer.
“Through our Precision Health vision, Stanford Medicine is committed to providing more personalized health care that is tailored to each individual,” said Lloyd Minor, MD, dean of the Stanford University School of Medicine. “Planning for the Hadron Center embodies this commitment, as we seek to identify optimal ways to offer targeted treatment that both reduces harm and promotes healing.”
This project would be the first of its kind in the nation and serves as an excellent example of public-private collaboration to further research and clinical care, using cutting-edge cancer therapy.
The Hadron Center would significantly complement VAPAHCS’s mission to provide the most advanced care for Veterans, by offering those with cancer access to Hadron therapy treatments and participation in clinical trials.
U.S. Department of Veterans Affairs | 810 Vermont Avenue, NW Washington DC 20420
Last updated Oct 17, 2016